Page last updated: 2024-11-07

penicillamine and Leishmaniasis, American

penicillamine has been researched along with Leishmaniasis, American in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
López-Jaramillo, P1
Ruano, C1
Rivera, J1
Terán, E1
Salazar-Irigoyen, R1
Esplugues, JV1
Moncada, S1
Niedbala, W1
Wei, XQ1
Piedrafita, D1
Xu, D1
Liew, FY1

Trials

1 trial available for penicillamine and Leishmaniasis, American

ArticleYear
Treatment of cutaneous leishmaniasis with nitric-oxide donor.
    Lancet (London, England), 1998, Apr-18, Volume: 351, Issue:9110

    Topics: Administration, Topical; Adolescent; Adult; Animals; Child; Child, Preschool; Dose-Response Relation

1998

Other Studies

1 other study available for penicillamine and Leishmaniasis, American

ArticleYear
Effects of nitric oxide on the induction and differentiation of Th1 cells.
    European journal of immunology, 1999, Volume: 29, Issue:8

    Topics: Animals; CD4-Positive T-Lymphocytes; Cell Differentiation; Clone Cells; Drug Synergism; Enzyme Inhib

1999